TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network. March 26, 2004
TCL Archive In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set January 22, 1982